Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2003
12/04/2003WO2003008579A3 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby
12/04/2003WO2003008547A3 Non-affinity based isotope tagged peptides and methods for using the same
12/04/2003WO2003007803A3 Methods for diagnosing and treating alzheimer's disease and parkinson's disease
12/04/2003WO2003006996A3 Natural ligand of gpcr chemr23 and uses thereof
12/04/2003WO2003006504A3 Allelic variants of gpr50
12/04/2003WO2003005032A3 Method for screening molecules which can bind to the gp120 protein of the immunodeficiency virus
12/04/2003WO2003004601A3 New assays for preimplantation factor and preimplantation factor peptides
12/04/2003WO2003004531A3 Regulation of human somatostatin receptor-like protein
12/04/2003WO2003002724A3 Proteins, druggable regions of proteins and target analysis for chemistry of therapeutics
12/04/2003WO2003001876A3 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
12/04/2003WO2003000853A3 Protein aggregation assays and uses thereof
12/04/2003WO2002102977A3 Characterization of a membrane estrogen receptor
12/04/2003WO2002102310A3 Proteins associated with cell growth, differentiation, and death
12/04/2003WO2002101394A3 Screening method which uses bnpi and dnpi
12/04/2003WO2002099424A3 Acridone derivatives as labels for fluorescence detection of target materials
12/04/2003WO2002099068A3 LCES AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/04/2003WO2002097126A3 Method for detecting gram-positive bacteria having a high gc content
12/04/2003WO2002090992A3 Screening method
12/04/2003WO2002090923A3 Methods for assembling protein microarrays
12/04/2003WO2002088678A3 Portable apparatus for the non-destructive measurement of the internal quality of vegetable products
12/04/2003WO2002087499A3 Cells for detection of enteroviruses
12/04/2003WO2002086494A3 Method for the relative determination of physicochemical properties
12/04/2003WO2002086134A3 Buffer solution for electroporation and a method comprising the use of the same
12/04/2003WO2002086090A3 Identification of essential genes of aspegillus fumigatus and methods of use
12/04/2003WO2002082077A3 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
12/04/2003WO2002079382A3 B-ephrin regulation of g-protein coupled chemoattraction; compositions and methods of use
12/04/2003WO2002074987A3 Quantitative diagnostic analysis of hypertonia
12/04/2003WO2002074986A3 An early pre-symptomatic prion diagnostic blood test for encephalopathies
12/04/2003WO2002073208A3 Anti-epileptogenic agents
12/04/2003WO2002073195A3 Diagnostic of metal allergy through cytokine release by t-cells in vitro
12/04/2003WO2002070708A3 Glutamate receptor modulatory proteins and nucleic acids encoding them
12/04/2003WO2002070555A3 Method of modulating the proliferation of medullary thyroid carcinoma cells
12/04/2003WO2002064827A3 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof
12/04/2003WO2002062839A3 Markers of unstable atherosclerotic plaques
12/04/2003WO2002057427A3 Mammalian tumor susceptibility gene products and their uses
12/04/2003WO2002038810A3 Compositions and methods relating to prostate specific genes and proteins
12/04/2003WO2002036808A8 Compositions and methods relating to prostate specific genes and proteins
12/04/2003WO2002030462A3 Hedgehog antagonists, methods and uses related thereto
12/04/2003WO2002024947A3 Cancer associated protein kinases and their uses
12/04/2003WO2002021127A3 Method for analysing the ageing of the skin
12/04/2003WO2001072771A3 Insulin and igf-1 receptor agonists and antagonists
12/04/2003US20030226159 Preparation of transgenic animal model for monitoring tumor development and treatments using stem cells
12/04/2003US20030226154 Pathophysiology associated with a single gene (MASS 1) mutation underlying the robust audiogenic seizure phenotype in frings mice
12/04/2003US20030225529 Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent for environmental testing thereby
12/04/2003US20030225528 Gene expression profiling in biopsied tumor tissues
12/04/2003US20030225527 Crystals and structures of MST3
12/04/2003US20030225526 Molecular cancer diagnosis using tumor gene expression signature
12/04/2003US20030225362 Systems and methods for monitoring health and delivering drugs transdermally
12/04/2003US20030225341 Method and device for measuring blood gas parameters
12/04/2003US20030225322 Optical waveguide sensor, device, system and method for glucose measurement
12/04/2003US20030225251 Specificity exchangers that redirect antibodies to a pathogen
12/04/2003US20030225248 186 human secreted proteins
12/04/2003US20030225247 Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses
12/04/2003US20030225162 Monitoring and evaluation, to reduce side effects such as metabolic, cardiovascular or muscular disorders, during prophylaxis of urogenital disorders, then admininstering carnitine isomers
12/04/2003US20030225117 Use of NAD(P)H oxidase inhibitors to increase cellular uptake of glucose and in the treatment and/or prevention of diseases caused by insulin resistance or diseases related thereto, such as type II diabetes
12/04/2003US20030225046 Through modulation of the interaction of such hormone receptors with phosphatidylinositol-3 kinase
12/04/2003US20030225026 Inhibiting receptor-type tyrosine phosphatase epsilon activity or expression in tumor cells
12/04/2003US20030225025 MDA-7 proteins and methods of use thereof
12/04/2003US20030225024 Method for deriving epitopes
12/04/2003US20030225011 Phospholipase A2 expression and activity and use thereof for diagnosis, prognostication, prevention and treatment of neural inflammatory and demyelinating disease
12/04/2003US20030224982 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/04/2003US20030224981 Administering a protein comprising at least one binding domain for a laminin and at least one binding domain for alpha-dystroglycan or a nucleic acid encoding the protein
12/04/2003US20030224980 Diagnostic reagents for human cytomegalovirus and methods of use
12/04/2003US20030224968 Identifying subjects who have or are at risk for developing Hereditary Spastic Paraplegia by detecting the presence or absence of one or more variations in the atlastin gene or treating HSP by administering atlastin
12/04/2003US20030224967 Use of mass spectrometry to analyze peptides and amino acids in the field of proteomics
12/04/2003US20030224534 Using particle agglutination properties of substances to measure and/or determine content of blood, urine and/or ascites
12/04/2003US20030224530 High throughput assay which resists deformation, shrinkage and evaporation and utilizes sensing material immobilized on solid support; microfluidics
12/04/2003US20030224526 Sensor devices comprising molecularly imprinted polymers for use in real-time detection of cortisol levels in a fluid sample, and methods for using such devices to detect cortisol levels in real time
12/04/2003US20030224525 Enhanced photophysics of conjugated polymers
12/04/2003US20030224523 Cartridge arrangement, fluid analyzer arrangement, and methods
12/04/2003US20030224487 Novel cytokine zcytor17 ligand
12/04/2003US20030224474 Apparatus for detection of rohypnol, gamma hydroxyl butyrate, and ketamine; drug screening; colorimetric analysis
12/04/2003US20030224471 Apparatus for measuring serum cholesterol associated with high-density lipoproteins (HDL) in blood fluid sample; diagnosing cardiovascular disorders and coronary artery disease
12/04/2003US20030224470 Method of diagnosing statin myopathy
12/04/2003US20030224469 Using fluorescence polarization to characterize binding characteristics of compounds; drug screening/design; high throughput assay
12/04/2003US20030224468 By interacting with periplasmic molecular chaperones the assembly of pili is prevented or inhibited and thereby the infectivity of the bacteria is diminished
12/04/2003US20030224467 AIB1 as a prognostic marker and predictor of resistance to endocrine therapy
12/04/2003US20030224466 Neuroblastoma cell lines expressing the alpha2delta subunit of calcium channels and methods therefore
12/04/2003US20030224465 Diagnostic and monitoring methods for cancer
12/04/2003US20030224464 Secreted caveolin as a marker for prostate cancer
12/04/2003US20030224463 Using aberrant nucleotide sequence repair to diagnose and determine cancer predisposition
12/04/2003US20030224462 Immunoassay for cancer
12/04/2003US20030224461 Nucleic acids, proteins, and antibodies
12/04/2003US20030224459 Protein detection method
12/04/2003US20030224458 Novel human G-protein coupled receptor, HGPRBMY23, expressed highly in kidney
12/04/2003US20030224457 Methods and apparatus for blood typing with optical bio-discs
12/04/2003US20030224455 Involving a haemodynamic deficit such as terminal heart failure, acute myocardial infarction, or cardiac hypofunctionality subsequent to heart transplantation
12/04/2003US20030224454 Human solute carrier family 7, member 11 (hSLC7A11)
12/04/2003US20030224452 Preparing immunoglobulin for use as tool in immunoassay for determining pregnancy in ruminants; animal husbandry; in vito fertilization; veterinary medicine
12/04/2003US20030224449 Composition comprising alginic acid and alginates for increasing immunological adhesion of immunoassays
12/04/2003US20030224448 Methods for structural analysis of proteins
12/04/2003US20030224447 For preparation of immunogens, antibodies and conjugates, for use in competitive immunoassays for the detection of ketamine ((+-)-2-(o-chlorophenyl)-2-(methylamino)cyclohexanone) and its primary metabolite, norketamine
12/04/2003US20030224446 Method of predicting cytokine response to tissue injury
12/04/2003US20030224445 Using lipoprotein concentration of fat granules, urinary lipomicrons and oval fat to diagnosis kidney disorders
12/04/2003US20030224444 Antibodies to native conformations of membrane proteins
12/04/2003US20030224441 Measuring chip for surface plasmon resonance biosensor and method for producing the same
12/04/2003US20030224437 Discriminately identifying nucleic acid sequences of coliform bacteria; high throughput assay
12/04/2003US20030224436 Microfluidic apparatus and method for enriching and analyzing biological cells
12/04/2003US20030224435 Detection of abused substances and their metabolites using nucleic acid sensor molecules
12/04/2003US20030224426 Human G-protein chemokine receptor HSATU68
1 ... 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 ... 3937